Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026

Same author

Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cells.

Frontiers in immunology·2026

Same author

Type 1-polarized DC immunotherapeutic contains heterogeneous populations with IL-12p70 production restricted to a rare subset.

bioRxiv : the preprint server for biology·2026

Same author

Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIV.

EBioMedicine·2026

Same author

Herpesvirus and GB Virus C Infections in Men With and Without HIV-1 Who Have Sex with Men.

AIDS research and human retroviruses·2026

Same author

High Enrollment and Representativeness of MACS and WIHS Study Participants in the newly merged MACS/WIHS Combined Cohort Study (MWCCS).

AJE advances : research in epidemiology·2026

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

Regulatory T cells in HIV immunotherapy.

Bernard Jc Macatangay¹, Charles R Rinaldo

¹HIV/AIDS Program, Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

|April 5, 2011

Summary

Regulatory T cells (Tregs) have a complex role in HIV infection, potentially hindering immune control. Further research is needed to target Treg function for effective HIV immunotherapies without increasing immune activation.

Area of Science:

Immunology
Virology
Infectious Diseases

Background:

Regulatory T cells (Tregs) are crucial for immune homeostasis.
Their precise role in HIV pathogenesis remains unclear, with evidence suggesting both detrimental and beneficial functions.
Existing immunotherapeutic strategies for HIV sometimes reveal an antagonistic role for Tregs.

Purpose of the Study:

To investigate the complex role of Tregs in HIV infection.
To identify strategies for modulating Treg function to enhance immune control of HIV.
To avoid exacerbating immune activation in chronic HIV infection.

Main Methods:

Review of existing research on Treg function in HIV infection.
Analysis of immunotherapeutic strategies and their impact on Tregs.

More Related Videos

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function

Published on: October 15, 2013

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

Exploration of HIV immunopathogenesis and regulatory networks.

Main Results:

The role of Tregs in HIV pathogenesis is not definitively established.
Treg-targeted immunotherapies may have unintended consequences.
Current Treg modulation strategies may not be directly applicable to HIV.

Conclusions:

Targeting Tregs in HIV requires careful consideration of the unique immunopathogenesis.
Further studies are essential to understand specific Treg-mediated pathways in HIV.
Developing effective HIV immunotherapies necessitates elucidating and altering key immunoregulatory networks.